Profund Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
512
-50
-9% -$23.1K 0.01% 876
2026
Q1
$270K Buy
562
+65
+13% +$33.3K 0.01% 817
2025
Q4
$279K Sell
497
-21
-4% -$11.9K 0.01% 929
2025
Q3
$266K Buy
+518
New +$226K 0.01% 803
2025
Q1
Sell
-631
Closed -$210K 1062
2024
Q4
$210K Sell
631
-101
-14% -$34.3K 0.01% 986
2024
Q3
$244K Buy
732
+49
+7% +$18.6K 0.01% 931
2024
Q2
$281K Sell
683
-241
-26% -$95.4K 0.01% 755
2024
Q1
$373K Buy
924
+165
+22% +$58K 0.01% 721
2023
Q4
$233K Buy
+759
New +$205K 0.01% 937
2023
Q2
Sell
-1,357
Closed -$255K 1106
2023
Q1
$255K Sell
1,357
-2,887
-68% -$597K 0.02% 822
2022
Q4
$901K Buy
4,244
+76
+2% +$15.2K 0.06% 288
2022
Q3
$655K Sell
4,168
-391
-9% -$62.4K 0.05% 319
2022
Q2
$682K Sell
4,559
-1,017
-18% -$147K 0.04% 346
2022
Q1
$912K Sell
5,576
-638
-10% -$105K 0.04% 338
2021
Q4
$1.35M Sell
6,214
-661
-10% -$138K 0.04% 268
2021
Q3
$1.3M Buy
6,875
+4,557
+197% +$831K 0.04% 291
2021
Q2
$410K Sell
2,318
-10
-0.4% -$1.73K 0.01% 807
2021
Q1
$382K Sell
2,328
-337
-13% -$51.5K 0.01% 773
2020
Q4
$371K Buy
2,665
+186
+8% +$23.4K 0.02% 699
2020
Q3
$277K Buy
2,479
+41
+2% +$4.74K 0.01% 707
2020
Q2
$227K Buy
+2,438
New +$207K 0.01% 755
2020
Q1
Sell
-2,846
Closed -$239K 1012
2019
Q4
$239K Buy
2,846
+90
+3% +$6.97K 0.01% 1072
2019
Q3
$232K Buy
+2,756
New +$208K 0.01% 1096

Other funds holding MEDP

Profund Advisors's MEDP Position: Q2 2026 in Review

Profund Advisors reduced its Medpace (MEDP) stake by 8.9% in Q2 2026, selling an estimated $23.1K and leaving 512 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #876.

Profund Advisors first reported a position in MEDP in Q3 2019 and has held it in 23 quarters since. The position peaked at $1.35M in Q4 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Profund Advisors held 512 shares of Medpace worth $271K as of Q2 2026.
  • Profund Advisors sold 50 Medpace shares in Q2 2026, an estimated $23.1K.
  • Medpace made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #876 holding.
  • Profund Advisors first reported a position in Medpace in Q3 2019 and has held it in 23 quarters since.
  • Profund Advisors's Medpace position peaked at $1.35M in Q4 2021.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.